TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1-α

Endocrinology (United States)

Volumn 156, Issue 5, 2015, Pages 1770-1781

  Remels, A H V ^a   Gosker, H R ^a   Verhees, K J P ^a   Langen, R C J ^a   Schols, A M W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; CARBONATE DEHYDRATASE IX; FRUCTOSE 2,6 BISPHOSPHATASE; GLYCOGEN PHOSPHORYLASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; LACTIC ACID; MESSENGER RNA; PYRUVATE DEHYDROGENASE KINASE 4; TUMOR NECROSIS FACTOR ALPHA; UBIQUINOL CYTOCHROME C REDUCTASE; VASCULOTROPIN A; GLUCOSE; HIF1A PROTEIN, HUMAN; HIF1A PROTEIN, MOUSE; VEGFA PROTEIN, HUMAN;

AEROBIC METABOLISM; ANIMAL CELL; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; GLUCOSE TRANSPORT; GLYCOGEN ANALYSIS; GLYCOLYSIS; HUMAN; HUMAN TISSUE; MOUSE; MUSCLE BIOPSY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUADRICEPS FEMORIS MUSCLE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; CASE CONTROL STUDY; CELL LINE; DRUG EFFECTS; GENETICS; METABOLISM; SEVERITY OF ILLNESS INDEX; SKELETAL MUSCLE;

ANIMALS; CASE-CONTROL STUDIES; CELL LINE; GLUCOSE; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LACTIC ACID; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; NF-KAPPA B; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929001154     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1591     Document Type: Article

References (48)

1. Wells GD, Selvadurai H, Tein I. Bioenergetic provision of energy for muscular activity. Paediatr Respir Rev. 2009;10:83-90.
2. Der-Torossian H, Wysong A, Shadfar S, Willis MS, McDunn J, Couch ME. Metabolic derangements in the gastrocnemius and the effect of CompoundAtherapy in a murine model of cancer cachexia. J Cachexia Sarcopenia Muscle. 2013;4:145-155.
3. Gomes AP, Price NL, Ling AJ, et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155:1624-1638.
4. Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 1992;85:1364-1373.
5. Sullivan MJ, Hawthorne MH. Exercise intolerance in patients with chronic heart failure. Prog Cardiovasc Dis. 1995;38:1-22.
6. Eisner MD, Iribarren C, Blanc PD, et al. Development of disability in chronic obstructive pulmonary disease: beyond lung function. Thorax. 2011;66:108-114.
7. Park SW, Goodpaster BH, Strotmeyer ES, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes. 2006;55:1813-1818.
8. Remels AH, Gosker HR, Langen RC, Schols AM. The mechanisms of cachexia underlying muscle dysfunction inCOPD.J Appl Physiol. 2012;9:1253-1262.
9. Remels AH, Gosker HR, Schrauwen P, Langen RC, Schols AM. Peroxisome proliferator-activated receptors: a therapeutic target in COPD? Eur Respir J. 2008;31:502-508.
10. Gosker HR, Hesselink MK, Duimel H, Ward KA, Schols AM. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J. 2007;30:73-79.
11. Gosker HR, van Mameren H, van Dijk PJ, et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J. 2002;19:617-625.
12. Rabinovich RA, Bastos R, Ardite E, et al. Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J. 2007;29:643-650.
13. Saey D, Lemire BB, Gagnon P, et al. Quadriceps metabolism during constant work rate cycling exercise in chronic obstructive pulmonary disease. J Appl Physiol. 2011;110:116-124.
14. Franssen FM, Sauerwein HP, Ackermans MT, Rutten EP, Wouters EF, Schols AM. Increased postabsorptive and exercise-induced whole-body glucose production in patients with chronic obstructive pulmonary disease. Metabolism. 2011;60:957-964.
15. Green HJ, Bombardier E, Burnett M, et al. Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease. Am J Physiol Regul Integr Comp Physiol. 2008;295:R935-R941.
16. Green HJ, Burnett ME, D'Arsigny CL, O'Donnell DE, Ouyang J, Webb KA. Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease. J Appl Physiol. 2008;105:879-886.
17. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease.AmJ Respir Crit Care Med. 1995;151: 374-377.
18. Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3:637-658.
19. Remels AH, Gosker HR, Schrauwen P, et al. TNF-α impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J. 2010;24:5052-5062.
20. Zentella A, Manogue K, Cerami A. Cachectin/TNF-mediated lactate production in cultured myocytes is linked to activation of a futile substrate cycle. Cytokine. 1993;5:436-447.
21. Shibata T, Giaccia AJ, Brown JM. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther. 2000; 7:493-498.
22. van den Borst B, Slot IG, Hellwig VA, et al. Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD. J Appl Physiol. 2012;9:1319-1328.
23. Remels AH, Gosker HR, Bakker J, Guttridge DC, Schols AM, Langen RC. Regulation of skeletal muscle oxidative phenotype by classical NF-κB signalling. Biochim Biophys Acta. 2013;81:313-325.
24. Minchenko O, Opentanova I, Caro J. Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett. 2003;554:264-270.
25. Otake S, Kobayashi M, Narumi K, et al. Regulation of the expression and activity of glucose and lactic acid metabolism-related genes by protein kinase C in skeletal muscle cells. Biol Pharm Bull. 2013; 36:1435-1439.
26. Lundby C, Calbet JA, Robach P. The response of human skeletal muscle tissue to hypoxia. Cell Mol Life Sci. 2009;66:3615-3623.
27. Valerio A, Cardile A, Cozzi V, et al. TNF-α downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest. 2006;116:2791-2798.
28. Chen XH, Zhao YP, Xue M, et al. TNF-α induces mitochondrial dysfunction in 3T3-L1 adipocytes. Mol Cell Endocrinol. 2010;328: 63-69.
29. Cho SY, Park PJ, Shin ES, Lee JH, Chang HK, Lee TR. Proteomic analysis of mitochondrial proteins of basal and lipolytically (isoproterenol and TNF-α)-stimulated adipocytes. J Cell Biochem. 2009;106:257-266.
30. Suematsu N, Tsutsui H, Wen J, et al. Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation. 2003;107:1418-1423.
31. Spitzer JJ, Bagby GJ, Meszaros K, Lang CH. Altered control of carbohydrate metabolism in endotoxemia. Prog Clin Biol Res. 1989;286:145-165.
32. Benigni F, Atsumi T, Calandra T, et al. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest. 2000;106:1291-1300.
33. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;14:187-189.
34. Straub RH, Buttgereit F, Cutolo M. Alterations of the hypothalamic- pituitary-adrenal axis in systemic immune diseases-a role for misguided energy regulation. Clin Exp Rheumatol. 2011;29:S23-S31.
35. Straub RH, Cutolo M, Buttgereit F, Pongratz G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med. 2010;267:543-560.
36. Kawauchi K, Araki K, Tobiume K, Tanaka N. p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation. Nat Cell Biol. 2008;10:611-618.
37. Kang C, Li Ji L. Role of PGC-1α signaling in skeletal muscle health and disease. Ann NY Acad Sci. 2012;1271:110-117.
38. Goda N, Kanai M. Hypoxia-inducible factors and their roles in energy metabolism. Int J Hematol. 2012;95:457-463.
39. Scharte M, Han X, Bertges DJ, Fink MP, Delude RL. Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes. Am J Physiol Gastrointest Liver Physiol. 2003;284:G373-G384.
40. Scharte M, Han X, Uchiyama T, Tawadrous Z, Delude RL, Fink MP. LPS increases hepatic HIF-1α protein and expression of the HIF-1-dependent gene aldolaseAin rats. J Surg Res. 2006;135:262-267.
41. Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-κB in hypoxic inflammation. J Physiol. 2008;586: 4055-4059.
42. Zhou J, Schmid T, Brune B. Tumor necrosis factor-α causes accumulation of a ubiquitinated form of hypoxia inducible factor-1α through a nuclear factor-κB-dependent pathway. Mol Biol Cell. 2003;14:2216-2225.
43. van Uden P, Kenneth NS, Rocha S. Regulation of hypoxia-inducible factor-1α by NF-κB. Biochem J. 2008;412:477-484.
44. Rius J, Guma M, Schachtrup C, et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF- 1α. Nature. 2008;453:807-811.
45. Belaiba RS, Bonello S, Zahringer C, et al. Hypoxia up-regulates hypoxia-inducible factor-1α transcription by involving phosphatidylinositol 3-kinase and nuclear factor κB in pulmonary artery smooth muscle cells. Mol Biol Cell. 2007;18:4691-4697.
46. Jatta K, Eliason G, Portela-GomesGM, et al. Overexpression of von Hippel-Lindau protein in skeletal muscles of patients with chronic obstructive pulmonary disease. J Clin Pathol. 2009;62:70-76.
47. Tornatore L, Thotakura AK, Bennett J, MorettiM, Franzoso G. The nuclear factor κB signaling pathway: integrating metabolism with inflammation. Trends Cell Biol. 2012;22:557-566.
48. Agusti A, MorlaM, Sauleda J, Saus C, Busquets X. NF-κBactivation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax. 2004;59:483-487.